Salivary gland carcinomas with unusual presentations
- 30 January 2019
- journal article
- letter
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 58 (3) , 382-384
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Significant and durable clinical benefit from trastuzumab in 2 patients with HER2‐amplified salivary gland cancer and a review of the literatureHead & Neck, 2016
- Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breastHistopathology, 2016
- Pleomorphic adenoma of the parotid gland 1985–2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformationHead & Neck, 2015
- A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancerInvestigational New Drugs, 2014
- Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasisSurgical Oncology, 2013
- Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Radiotherapy alone or combined with surgery for salivary gland carcinomaCancer, 2005
- The role of radiotherapy in the treatment of malignant salivary gland tumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Sarcomatoid Variant of Salivary Duct CarcinomaAmerican Journal of Clinical Pathology, 2004
- Sarcomatoid salivary duct carcinoma of the parotid glandHuman Pathology, 2000